PONZ DE LEON, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 25.392
EU - Europa 12.201
AS - Asia 2.913
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 3
OC - Oceania 1
Totale 40.546
Nazione #
US - Stati Uniti d'America 25.327
GB - Regno Unito 6.371
SE - Svezia 1.445
CN - Cina 1.124
DE - Germania 1.058
UA - Ucraina 1.017
IT - Italia 859
TR - Turchia 795
HK - Hong Kong 645
FI - Finlandia 520
BG - Bulgaria 371
FR - Francia 185
SG - Singapore 156
BE - Belgio 146
IN - India 86
NL - Olanda 59
CA - Canada 55
IE - Irlanda 49
RU - Federazione Russa 38
KR - Corea 27
MY - Malesia 24
RO - Romania 24
VN - Vietnam 21
JP - Giappone 12
EU - Europa 11
CL - Cile 10
BR - Brasile 9
ES - Italia 9
IR - Iran 7
PL - Polonia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BZ - Belize 5
CH - Svizzera 5
GR - Grecia 5
MX - Messico 5
AT - Austria 4
DK - Danimarca 4
BD - Bangladesh 3
CZ - Repubblica Ceca 3
EE - Estonia 3
LT - Lituania 3
LU - Lussemburgo 3
TH - Thailandia 3
MD - Moldavia 2
MK - Macedonia 2
RS - Serbia 2
SA - Arabia Saudita 2
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MT - Malta 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 40.546
Città #
Southend 5.521
Fairfield 3.406
Woodbridge 2.649
Jacksonville 2.210
Houston 2.183
Chandler 1.835
Ashburn 1.695
Dearborn 1.425
Ann Arbor 1.336
Seattle 1.268
Wilmington 1.236
Cambridge 1.114
Nyköping 895
Hong Kong 643
Princeton 486
Beijing 461
Izmir 459
Sofia 371
Eugene 367
Modena 360
San Diego 351
Des Moines 282
Helsinki 160
Brussels 132
New York 129
London 126
Bremen 113
Grafing 101
Falls Church 99
Hefei 67
Boardman 66
Milan 62
Norwalk 60
Shanghai 57
Fremont 56
Kunming 52
Philadelphia 49
Dublin 47
Nanjing 47
Chiswick 42
Hounslow 38
Jinan 30
San Mateo 30
Ottawa 27
Redwood City 27
Verona 25
Kilburn 24
Ansbach 18
Auburn Hills 18
Toronto 18
Chicago 17
Dong Ket 17
Indiana 17
Nanchang 17
Augusta 16
Guangzhou 15
Acton 14
Leawood 14
Mountain View 14
Prescot 14
Waanrode 14
Fuzhou 13
Washington 13
Frankfurt am Main 12
Horia 12
Monmouth Junction 12
San Jose 12
Brooklyn 11
Saint Petersburg 11
Wandsworth 11
Southwark 10
Mumbai 9
Phoenix 9
Berlin 8
Dongguan 8
Edinburgh 8
Hanover 8
Islington 8
Los Angeles 8
New Bedfont 8
Wuhan 8
Yellow Springs 8
Zhengzhou 8
Chongqing 7
Cremona 7
Dallas 7
Rome 7
Shenyang 7
Singapore 7
Bologna 6
Las Vegas 6
Pune 6
Reggio Nell'emilia 6
Arceto 5
Atlanta 5
Bangalore 5
Belize City 5
Chengdu 5
Clearwater 5
Kraków 5
Totale 32.758
Nome #
Estimates of cancer burden in Italy 605
Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms. 232
Attenuated polyposis of the large bowel: a morphologic and molecular approach 230
Morphological and quantitative analysis of BCL6 expression in human colorectal carcinogenesis. 212
An unusual case of familial adenomatous polyposis with very early symptom occurrence 207
Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis 207
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors 200
Clinical features of colorectal cancer patients in advanced age: a population-based approach 194
Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature 194
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 190
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 189
Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages 188
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 188
Differentiated Thyroid Carcinoma (DTC) in a Young Woman with Peutz-Jeghers Syndrome: are these Two Conditions Associated? 187
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 186
Aetiology of colorectal cancer and relevance of monogenic inheritance. 185
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 184
Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. 181
The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and women 179
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. 177
Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. 177
Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study 177
Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. 176
Lymph node micrometastasis and survival of patients with Stage I (Dukes' A) colorectal carcinoma. 176
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 176
Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: A population-based study 175
Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer 175
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma. 174
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 173
PLZF expression during colorectal cancer development and in normal colorectal mucosa according to body size, as marker of colorectal cancer risk. 173
Microsatellite instability and colorectal cancer prognosis. 172
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 172
Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life. 171
Decrease in plasma tryptophan after a tryptophan-free amino acid solution. A comparison between cirrhotic and control subjects 169
Alteration of drug metabolism during cholestasis in man 169
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 168
Aberrant crypt foci in patients with colorectal cancer 164
A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability. 163
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 162
Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome. 161
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes. 160
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis 158
Incidence trend of malignant polyps through the data of a specialized colorectal cancer registry: clinical features and effect of screening. 157
Peutz-Jeghers syndrome: a systematic review and recommendations for management 157
Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme 157
Cancer prevalence in Italian cancer registry areas: The ITAPREVAL study 157
Analysis of mismatch repair gene mutations in Turkish HNPCC patients. 156
Cholesterol esterase activity of human intestinal mucosa 155
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary 155
A case of pneumatosis cystoides intestinalis mimicking familial adenomatous polyposis. 155
K-ras and p53 mutations in human colorectal aberrant crypt foci 154
Carcinoma papillare e Sindrome di Peutz-Jeghers: una rara associazione 154
Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma. 153
Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size 153
Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients 153
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 153
Assessment of pathogenicity criteria for constitutional missense mutations of the hereditary nonpolyposis colorectal cancer genes MLH1 and MSH2 152
Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes 152
Variations in the survival adult cancer patients in Italy 152
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study 152
Identification of Lynch syndrome among patients with colorectal cancer. 152
Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm? 152
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 151
Surgical management of the duodenal manifestations of familial adenomatous polyposis 150
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 149
In response. Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability. 148
Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study 148
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 148
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 148
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 147
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 147
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 146
Effects of acute changes of bile acid pool composition on biliary lipid secretion 146
Integrated analysis of unclassified variants in mismatch repair genes. 145
Physiological factors influencing serum bile acid levels 145
Duodenal carcinoma in a 37-year-old man with Cowden/Bannayan syndrome. 144
First observation of microadenomas in the ileal mucosa of patients with familial adenomatous polyposis and colectomies 144
Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry 144
Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: a population-based study 143
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 143
MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria 143
Neutrophil gelatinase-associated lipocalin: A new prognostic marker in stage i colorectal carcinoma? 143
Attività citoproliferativa della mucosa rettale in pazienti con neoplasie del grosso intestino 143
The influence of age on colonic epithelial cell proliferation 142
Clinical features and colorectal cancer survival: an attempt to explain differences between two different Italian regions. 142
Regional inequalities in cancer care persist in Italy and can influence survival. 142
ANTIOXIDANT VITAMINS OR LACTULOSE AS CHEMOPREVENTIVE AGENTS FOR COLORECTAL CANCER 142
Estimates of cancer burden in Emilia-Romagna 142
Alteration of drug metabolism in Gilbert's syndrome 141
Bile lipid composition and bile acid pool size in diabetes 141
A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability. 141
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. 141
Clinical and biologic features of adenomatosis coli in Northern Italy 141
What should we advise about alcohol consumption. 140
The EUROCARE-3 database: Methodology of data collection, standardisation, quality control and statistical analysis 140
MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events 140
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 140
Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel 139
Survival analysis in families affected by hereditary non-polyposis colorectal cancer 139
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 139
Totale 16.594
Categoria #
all - tutte 148.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.137


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.301 0 0 0 0 0 0 0 0 269 442 1.200 1.390
2019/20209.522 891 604 324 535 1.021 1.388 1.578 821 1.158 304 538 360
2020/20216.537 702 235 561 626 865 399 641 843 276 755 352 282
2021/20225.836 154 907 466 488 134 285 358 273 633 392 1.072 674
2022/20235.191 686 528 321 499 628 951 90 464 624 46 205 149
2023/20242.673 135 215 207 221 832 257 298 435 73 0 0 0
Totale 40.812